Clinical Trial Update: A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing safety and clinical experience with nesiritide (NATRECOR) in patients with worsening congestive heart failure who requir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Heart Failure, Congestive, Heart Decompensation | Phase 3 | Status: COMPLETED